tirzepatide blood pressure reduction and reduction: stratified analyses of the SURMOUNT-1 randomised controlled trial Tirzepatide's Prediabetes and Hypertension Impact

Efficacy and safety of dulaglutide added onto pioglitazone and metformin versus exenatide in type 2 diabetes in a randomized controlled trial (AWARD-1)

Severe adverse events interfering with daily activities occur in approximately 3% of Rybelsus patients and 5.7% of Mounjaro patients at maximum doses

Clinical data does not indicate that injecting semaglutide induces acute dizziness

Many pharmacies and healthcare facilities offer medication disposal services, or community disposal events may be available

These combined effects typically result in spontaneous reduction of caloric intake, which contributes to the medication's efficacy in glycemic control and weight loss

Document baseline blood pressure, current antihypertensive medications, and cardiovascular history